Company Overview
22nd Century Group, Inc., a tobacco products company, manufactures, distributes, and sells proprietary new reduced nicotine tobacco products in the United States. The company offers reduced nicotine content tobacco and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands, as well as turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Mocksville, North Carolina.
Why Investors Should Care
Net profit has compounded at 30.5% per year over the last five years.
Carries low leverage with a debt-to-equity ratio of 0.06.
Recent Developments
- Dec 2025 Revenue of $7.05M (-40.7% YoY); net profit $-5.05M.
- Trailing 12 Months Year-on-year growth — revenue -43.3%.
- 5-Year Trend Long-term compounding — revenue CAGR -44.2%, profit CAGR 30.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -44.17% |
| 1 Year: | -43.30% |
Compounded Profit Growth
| 5 Years: | 30.52% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -99.46% |
| 6 Months: | -97.40% |
| 3 Months: | -87.18% |
| 1 Month: | -7.19% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)34.29 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 30.5% over 5 years.
CONS
- Revenue declined at -44.2% CAGR over 5 years.
- Trading 99.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | XXII 22nd Century Group, Inc. | 4.00 | -0.01 | $1.38M | 0.00% | -59.19% | -103.55% | -44.17% | 30.52% |
| 2 | WMT Walmart Inc. SPX | 111.20 | 39.15 | $884.94B | 0.89% | 18.21% | 24.13% | 5.27% | 23.30% |
| 3 | COST Costco Wholesale Corporation NDXSPX | 951.89 | 48.03 | $422.14B | 0.63% | 25.96% | 29.15% | 8.16% | 11.45% |
| 4 | KO The Coca-Cola Company SPX | 87.59 | 27.54 | $376.85B | 2.52% | 16.47% | 43.37% | 2.86% | 4.46% |
| 5 | PG The Procter & Gamble Company SPX | 144.49 | 21.12 | $336.46B | 2.92% | 22.93% | 31.11% | 0.36% | 1.66% |
| 6 | PM Philip Morris International Inc. SPX | 190.82 | 26.84 | $297.40B | 3.34% | 34.03% | -113.55% | -1.69% | 3.57% |
| 7 | PEP PepsiCo, Inc. NDXSPX | 139.56 | 18.29 | $190.64B | 4.37% | 15.41% | 51.51% | 4.93% | 2.11% |
| 8 | MO Altria Group, Inc. SPX | 68.33 | 14.27 | $114.10B | 6.04% | 38.27% | - | 1.24% | -1.89% |
| 9 | MNST Monster Beverage Corporation NDXSPX | 96.38 | 46.56 | $94.26B | 0.00% | 28.33% | 26.65% | 13.03% | 14.82% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 2.27M | 2.23M | 1.50M | 1.05M | 1.29M |
| Cost of Revenue | - | 2.88M | 2.86M | 2.56M | 1.88M | 1.93M |
| Gross Profit | - | -609.00K | -635.00K | -1.06M | -834.00K | -636.00K |
| Operating Expenses | - | 1.96M | 2.35M | 2.15M | 1.82M | 2.40M |
| Operating Income | - | -2.57M | -2.98M | -3.21M | -2.65M | -3.04M |
| EBITDA | - | -2.42M | -2.67M | -2.92M | -2.51M | -2.76M |
| Interest Expense | - | 558.00K | 351.00K | 534.00K | 12.00K | 11.00K |
| Pretax Income | - | -3.27M | -3.33M | -3.76M | -2.78M | -3.02M |
| Tax Provision | - | 0 | -34.00K | 0 | 6.00K | 0 |
| Net Income | - | -4.33M | -3.41M | 5.49M | -2.81M | -3.26M |
| Diluted EPS | - | -10,929.29 | -2,229.71 | -84.00 | - | -361.60 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 40.50M | 16.20M | 11.88M | 7.05M |
| Cost of Revenue | - | 38.65M | 24.89M | 14.28M | 10.19M |
| Gross Profit | - | 1.85M | -8.70M | -2.40M | -3.14M |
| Operating Expenses | - | 35.81M | 33.71M | 11.42M | 8.28M |
| Operating Income | - | -33.96M | -42.40M | -13.82M | -11.42M |
| EBITDA | - | -32.89M | -40.41M | -12.11M | -10.53M |
| Interest Expense | - | 55.00K | 9.37M | 2.09M | 1.46M |
| Pretax Income | - | -36.53M | -54.64M | -15.46M | -13.14M |
| Tax Provision | - | 21.00K | 47.00K | 30.00K | -28.00K |
| Net Income | - | -59.80M | -140.78M | -15.16M | -5.05M |
| Diluted EPS | - | -3,147,421.05 | -75,383,500.00 | -242,542.86 | -1,057.40 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 114.65M | 27.50M | 21.67M | 27.02M |
| Current Assets | - | 44.60M | 16.28M | 11.52M | 17.63M |
| Cash & Equivalents | - | 2.21M | 2.06M | 4.42M | 7.15M |
| Inventory | - | 7.27M | 4.35M | 2.02M | 4.33M |
| Receivables | - | 1.36M | 1.67M | 1.70M | 3.59M |
| Total Liabilities | - | 18.68M | 35.91M | 17.66M | 11.27M |
| Current Liabilities | - | 13.02M | 25.03M | 9.96M | 7.27M |
| Long Term Debt | - | 3.00M | 8.06M | 5.17M | 504.00K |
| Total Debt | - | 1.65M | 16.38M | 8.62M | 1.48M |
| Total Equity | - | 95.97M | -8.41M | 4.01M | 15.76M |
| Shares Outstanding | - | 19 | 2 | 105 | 25.52K |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -51.71M | -54.99M | -14.35M | -7.72M |
| Investing Cash Flow | - | 22.58M | 16.82M | -139.00K | -505.00K |
| Financing Cash Flow | - | 30.82M | 37.21M | 16.85M | 10.96M |
| Capital Expenditure | - | -4.43M | -5.62M | -161.00K | -875.00K |
| Free Cash Flow | - | -56.14M | -60.60M | -14.51M | -8.60M |
| Net Change in Cash | - | 1.68M | -962.00K | 2.36M | 2.73M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 4.6% | -53.7% | -20.2% | -44.5% |
| Operating Margin % | - | -83.9% | -261.8% | -116.3% | -162.0% |
| Net Margin % | - | -147.7% | -869.2% | -127.7% | -71.7% |
| ROE % | - | -62.3% | 1,673.9% | -378.0% | -32.1% |
| ROCE % | - | -33.4% | -1,717.5% | -118.0% | -57.8% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Anson Funds Management LP | 0.49% | 2.54K | $10.18K |
| 2 | Geode Capital Management, LLC | 0.15% | 777 | $3.11K |
| 3 | UBS Group AG | 0.04% | 203 | $812 |
| 4 | Vanguard Fiduciary Trust Co | 0.03% | 159 | $636 |
| 5 | Farther Finance Advisors, Llc | - | 5 | $20 |
| 6 | IFP Advisors, Inc | - | 2 | $8 |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for XXII
XXII — Frequently Asked Questions
What is the current share price of 22nd Century Group, Inc. (XXII)?
As of 2026-08-02 19:16 PDT, 22nd Century Group, Inc. (XXII) trades at $4.00 on NasdaqCM. Its 52-week range is $3.72 to $801.00.
What is the market capitalisation of XXII?
22nd Century Group, Inc. (XXII) has a market capitalisation of $1.38M on NasdaqCM.
What is the P/E ratio of XXII?
XXII trades at a trailing price-to-earnings (P/E) ratio of -0.01. The industry average P/E is 21.13. Its price-to-book (P/B) ratio is 0.01.
What is the return on equity (ROE) of XXII?
XXII has a return on equity (ROE) of -103.55%. Its return on capital employed (ROCE) is -59.19%.
Is XXII a good stock to buy?
This page provides a data-driven analysis of 22nd Century Group, Inc. (XXII), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.